Latest Breaking News On - Quotient sciences in miami - Page 1 : comparemela.com

South Rampart Pharma Successfully Completes Phase 1 Study and Expands Phase 2 Plans to Include Neuropathic and Acute Pain Trials

South Rampart Pharma Successfully Completes Phase 1 Study and Expands Phase 2 Plans to Include Neuropathic and Acute Pain Trials
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesJosh blacherHernan bazanHealth national survey on drugMental health indicatorsMental health services administrationPrnewswire south rampart pharma incNational survey on drugRampart pharma incQuotient sciences in miamiRampart pharma successfully completes phaseExpands phaseInclude neuropathicAcute painRampart pharmaQuotient sciences

South Rampart Pharma Issued Composition of Matter Patent for Novel Non-Toxic Treatment for Pain

- New patent grant further secures South Rampart s competitive position in next-generation and disruptive investigational drugs for acute pain -NE.

United statesWilliamk schmidtGideon broshyMaxim jacobsHernan bazanNeuroscience centerLouisiana state university health sciences centerSmall business innovation researchAmerica seed fundNational academy of sciencesHealth care professionalsResearch development fundingQuotient sciences in miamiNational institute of neurological disordersSouth rampartRampart pharma

South Rampart Pharma Receives Year 3 of NIH Fast-Track STTR Commercialization Grant

South Rampart Pharma Receives Year 3 of NIH Fast-Track STTR Commercialization Grant - read this article along with other careers information, tips and advice on BioSpace

United statesWilliamk schmidtGideon broshyMaxim jacobsHernan bazanNeuroscience centerLouisiana state university health sciences centerSmall business innovation researchNational institutes of healthAmerica seed fundNational academy of sciencesHealth care professionalsResearch development fundingSmall business technology transferQuotient sciences in miamiNational institute of neurological disorders

South Rampart Pharma Receives Year 3 of NIH Fast-Track STTR Commercialization Grant

/PRNewswire/ South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the.

United statesWilliamk schmidtGideon broshyMaxim jacobsHernan bazanNeuroscience centerLouisiana state university health sciences centerSmall business innovation researchNational institutes of healthAmerica seed fundNational academy of sciencesHealth care professionalsResearch development fundingSmall business technology transferQuotient sciences in miamiNational institute of neurological disorders

South Rampart Pharma Announces Late-Breaking Presentation at IASP 2022 World Congress on Pain

NEW ORLEANS, Aug. 25, 2022 /PRNewswire/ South Rampart Pharma ( South Rampart or the Company ), a clinical-stage life science company advancin.

United statesWilliamk schmidtGideon broshyMaxim jacobsHernan bazanNeuroscience centerInternational association for the study of painLouisiana state university health sciences centerSmall business innovation researchWorld congress on painAmerica seed fundNational academy of sciencesHealth care professionalsResearch development fundingQuotient sciences in miamiNational institute of neurological disorders